Global burden of cancers attributable to infections in 2012: a synthetic analysis

Cited by papers we hold 16

• NF-κB in inflammation and cancer · 2025
  No notice
• Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics · 2025
  No notice
• Fusobacterium nucleatum and cancer · 2022
  No notice
• Sexual Dimorphism and Gender in Infectious Diseases · 2021
  No notice
• The landscape of viral associations in human cancers · 2020
  Corrected
• The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease · 2020
  No notice
• The Role of the Cervicovaginal Microbiome on the Genesis and as a Biomarker of Premalignant Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer · 2019
  No notice
• Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening? · 2019
  No notice
• Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology · 2019
  No notice
• Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 · 2018
  No notice
• Human Gut Microbiota and Gastrointestinal Cancer · 2018
  No notice
• Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer · 2018
  No notice
• The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level · 2017
  No notice
• Microbiota, Inflammation and Colorectal Cancer · 2017
  No notice
• Variations in oral microbiota associated with oral cancer · 2017
  No notice
• Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.